[HTML][HTML] A validation study for the use of ROS1 immunohistochemical staining in screening for ROS1 translocations in lung cancer
P Viola, M Maurya, J Croud, J Gazdova… - Journal of Thoracic …, 2016 - Elsevier
Introduction The presence of ROS proto-oncogene 1, receptor tyrosine kinase gene (ROS1)
rearrangements in lung cancers confers sensitivity to ROS kinase inhibitors, including …
rearrangements in lung cancers confers sensitivity to ROS kinase inhibitors, including …
A Validation Study for the Use of ROS1 Immunohistochemical Staining in Screening for ROS1 Translocations in Lung Cancer
P Viola, M Maurya, J Croud… - Journal of thoracic …, 2016 - pubmed.ncbi.nlm.nih.gov
Introduction The presence of ROS proto-oncogene 1, receptor tyrosine kinase gene (ROS1)
rearrangements in lung cancers confers sensitivity to ROS kinase inhibitors, including …
rearrangements in lung cancers confers sensitivity to ROS kinase inhibitors, including …
[HTML][HTML] A Validation Study for the Use of ROS1 Immunohistochemical Staining in Screening for ROS1 Translocations in Lung Cancer
P Viola, M Maurya, J Croud, J Gazdova… - Journal of Thoracic …, 2016 - jto.org
Introduction The presence of ROS proto-oncogene 1, receptor tyrosine kinase gene (ROS1)
rearrangements in lung cancers confers sensitivity to ROS kinase inhibitors, including …
rearrangements in lung cancers confers sensitivity to ROS kinase inhibitors, including …
A validation study for the use of ROS1 immunohistochemical staining in screening for ROS1 translocations in lung cancer
P Viola, M Maurya, J Croud, J Gazdova… - Journal of thoracic …, 2016 - pure.qub.ac.uk
INTRODUCTION: The presence of ROS proto-oncogene 1, receptor tyrosine kinase gene
(ROS1) rearrangements in lung cancers confers sensitivity to ROS kinase inhibitors …
(ROS1) rearrangements in lung cancers confers sensitivity to ROS kinase inhibitors …
[PDF][PDF] A Validation Study for the Use of ROS1 Immunohistochemical Staining in Screening for ROS1 Translocations in Lung Cancer
P Viola, M Maurya, J Croud, J Gazdova… - Journal of Thoracic …, 2016 - academia.edu
Introduction: The presence of ROS proto-oncogene 1, receptor tyrosine kinase gene (ROS1)
rearrangements in lung cancers confers sensitivity to ROS kinase inhibitors, including …
rearrangements in lung cancers confers sensitivity to ROS kinase inhibitors, including …
[引用][C] A Validation Study for the Use of ROS1 Immunohistochemical Staining in Screening for ROS1 Translocations in Lung Cancer
P Viola, M Maurya, J Croud, J Gazdova… - Journal of Thoracic …, 2016 - cir.nii.ac.jp
A Validation Study for the Use of ROS1 Immunohistochemical Staining in Screening for
ROS1 Translocations in Lung Cancer | CiNii Research CiNii 国立情報学研究所 学術情報 …
ROS1 Translocations in Lung Cancer | CiNii Research CiNii 国立情報学研究所 学術情報 …
A Validation Study for the Use of ROS1 Immunohistochemical Staining in Screening for ROS1 Translocations in Lung Cancer.
P Viola, M Maurya, J Croud, J Gazdova… - Journal of Thoracic …, 2016 - europepmc.org
Methods A cohort of lung tumors negative for other common mutations related to targeted
therapies were screened to assess the sensitivity and specificity of IHC staining in detecting …
therapies were screened to assess the sensitivity and specificity of IHC staining in detecting …